Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-03

Clinical Trial Update: Ibuprofen in Migraine Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ibuprofen in patients with migraine without aura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Kecioren Education and Training Hospital | Conditions: Migraine Without Aura | Phase 4 | Status: COMPLETED